vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and RBB Bancorp (RBB). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $32.3M, roughly 1.3× RBB Bancorp). RBB Bancorp runs the higher net margin — 31.5% vs -26.0%, a 57.4% gap on every dollar of revenue. On growth, RBB Bancorp posted the faster year-over-year revenue change (12.6% vs -23.3%). RBB Bancorp produced more free cash flow last quarter ($42.6M vs $-9.2M). Over the past eight quarters, RBB Bancorp's revenue compounded faster (7.0% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

RBB Bancorp is a US-based financial holding company that operates Royal Business Bank as its primary banking subsidiary. It caters mainly to Asian American communities, small and medium-sized enterprises, real estate investors, and retail clients, offering comprehensive commercial banking, consumer lending, deposit services, and wealth management solutions across branches in key US coastal metropolitan areas.

PETS vs RBB — Head-to-Head

Bigger by revenue
PETS
PETS
1.3× larger
PETS
$40.7M
$32.3M
RBB
Growing faster (revenue YoY)
RBB
RBB
+35.8% gap
RBB
12.6%
-23.3%
PETS
Higher net margin
RBB
RBB
57.4% more per $
RBB
31.5%
-26.0%
PETS
More free cash flow
RBB
RBB
$51.8M more FCF
RBB
$42.6M
$-9.2M
PETS
Faster 2-yr revenue CAGR
RBB
RBB
Annualised
RBB
7.0%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
RBB
RBB
Revenue
$40.7M
$32.3M
Net Profit
$-10.6M
$10.2M
Gross Margin
23.3%
Operating Margin
-25.7%
39.5%
Net Margin
-26.0%
31.5%
Revenue YoY
-23.3%
12.6%
Net Profit YoY
-1392.6%
132.1%
EPS (diluted)
$-0.50
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
RBB
RBB
Q4 25
$40.7M
$32.3M
Q3 25
$44.4M
$32.6M
Q2 25
$51.2M
$35.8M
Q1 25
$50.8M
$28.5M
Q4 24
$52.0M
$28.7M
Q3 24
$58.0M
$30.3M
Q2 24
$66.2M
$27.5M
Q1 24
$65.1M
$28.2M
Net Profit
PETS
PETS
RBB
RBB
Q4 25
$-10.6M
$10.2M
Q3 25
$-8.5M
$10.1M
Q2 25
$-34.2M
$9.3M
Q1 25
$-11.6M
$2.3M
Q4 24
$-707.0K
$4.4M
Q3 24
$2.3M
$7.0M
Q2 24
$3.8M
$7.2M
Q1 24
$-5.0M
$8.0M
Gross Margin
PETS
PETS
RBB
RBB
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
RBB
RBB
Q4 25
-25.7%
39.5%
Q3 25
-18.9%
40.7%
Q2 25
-66.7%
36.1%
Q1 25
-11.9%
11.2%
Q4 24
-0.9%
17.6%
Q3 24
1.0%
31.6%
Q2 24
6.6%
35.6%
Q1 24
-5.9%
39.9%
Net Margin
PETS
PETS
RBB
RBB
Q4 25
-26.0%
31.5%
Q3 25
-19.2%
31.2%
Q2 25
-66.7%
26.1%
Q1 25
-22.9%
8.0%
Q4 24
-1.4%
15.3%
Q3 24
4.0%
23.1%
Q2 24
5.7%
26.4%
Q1 24
-7.7%
28.4%
EPS (diluted)
PETS
PETS
RBB
RBB
Q4 25
$-0.50
$0.59
Q3 25
$-0.41
$0.59
Q2 25
$-1.65
$0.52
Q1 25
$-0.56
$0.13
Q4 24
$-0.03
$0.26
Q3 24
$0.11
$0.39
Q2 24
$0.18
$0.39
Q1 24
$-0.24
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
RBB
RBB
Cash + ST InvestmentsLiquidity on hand
$26.9M
$212.3M
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$32.8M
$523.4M
Total Assets
$88.0M
$4.2B
Debt / EquityLower = less leverage
0.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
RBB
RBB
Q4 25
$26.9M
$212.3M
Q3 25
$36.1M
$234.9M
Q2 25
$41.1M
$191.9M
Q1 25
$54.7M
$238.8M
Q4 24
$50.1M
$257.7M
Q3 24
$52.0M
$349.4M
Q2 24
$46.0M
$252.8M
Q1 24
$55.3M
Total Debt
PETS
PETS
RBB
RBB
Q4 25
$119.9M
Q3 25
$119.8M
Q2 25
$119.7M
Q1 25
$119.6M
Q4 24
$119.5M
Q3 24
$119.4M
Q2 24
$119.3M
Q1 24
$119.2M
Stockholders' Equity
PETS
PETS
RBB
RBB
Q4 25
$32.8M
$523.4M
Q3 25
$43.1M
$514.3M
Q2 25
$51.5M
$517.7M
Q1 25
$85.1M
$510.3M
Q4 24
$96.2M
$507.9M
Q3 24
$96.4M
$509.7M
Q2 24
$93.5M
$511.3M
Q1 24
$96.7M
$514.0M
Total Assets
PETS
PETS
RBB
RBB
Q4 25
$88.0M
$4.2B
Q3 25
$100.3M
$4.2B
Q2 25
$109.8M
$4.1B
Q1 25
$148.7M
$4.0B
Q4 24
$144.8M
$4.0B
Q3 24
$146.0M
$4.0B
Q2 24
$152.7M
$3.9B
Q1 24
$169.9M
$3.9B
Debt / Equity
PETS
PETS
RBB
RBB
Q4 25
0.23×
Q3 25
0.23×
Q2 25
0.23×
Q1 25
0.23×
Q4 24
0.24×
Q3 24
0.23×
Q2 24
0.23×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
RBB
RBB
Operating Cash FlowLast quarter
$-9.2M
$43.4M
Free Cash FlowOCF − Capex
$-9.2M
$42.6M
FCF MarginFCF / Revenue
-22.7%
131.8%
Capex IntensityCapex / Revenue
0.1%
2.5%
Cash ConversionOCF / Net Profit
4.26×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$73.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
RBB
RBB
Q4 25
$-9.2M
$43.4M
Q3 25
$-2.2M
$2.1M
Q2 25
$-12.3M
$21.7M
Q1 25
$7.0M
$7.8M
Q4 24
$-1.2M
$58.5M
Q3 24
$7.4M
$24.5M
Q2 24
$-8.5M
$11.7M
Q1 24
$7.1M
$4.8M
Free Cash Flow
PETS
PETS
RBB
RBB
Q4 25
$-9.2M
$42.6M
Q3 25
$-4.8M
$1.8M
Q2 25
$-13.6M
$21.6M
Q1 25
$4.6M
$7.6M
Q4 24
$-1.9M
$57.7M
Q3 24
$6.1M
$24.2M
Q2 24
$-9.2M
$11.5M
Q1 24
$5.9M
$4.7M
FCF Margin
PETS
PETS
RBB
RBB
Q4 25
-22.7%
131.8%
Q3 25
-10.8%
5.4%
Q2 25
-26.5%
60.2%
Q1 25
9.1%
26.7%
Q4 24
-3.7%
201.0%
Q3 24
10.6%
80.0%
Q2 24
-13.9%
42.0%
Q1 24
9.0%
16.6%
Capex Intensity
PETS
PETS
RBB
RBB
Q4 25
0.1%
2.5%
Q3 25
5.9%
1.1%
Q2 25
2.5%
0.3%
Q1 25
4.7%
0.6%
Q4 24
1.5%
2.7%
Q3 24
2.2%
0.8%
Q2 24
1.0%
0.5%
Q1 24
1.9%
0.5%
Cash Conversion
PETS
PETS
RBB
RBB
Q4 25
4.26×
Q3 25
0.21×
Q2 25
2.32×
Q1 25
3.39×
Q4 24
13.34×
Q3 24
3.18×
3.50×
Q2 24
-2.27×
1.61×
Q1 24
0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

RBB
RBB

Segment breakdown not available.

Related Comparisons